ELMO3 and laryngeal carcinoma: The expression of ELMO3 has been reported in lung cancer [19–22], colorectal cancer [23], head and neck squamous cell carcinomas [24], and laryngeal cancer [25], etc. In these cancers, upregulation of ELMO3 is commonly involved in tumor development and metastasis formation.